101 related articles for article (PubMed ID: 22322138)
1. Reference values for thrombotic markers in children.
Sosothikul D; Kittikalayawong Y; Aungbamnet P; Buphachat C; Seksarn P
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):208-11. PubMed ID: 22322138
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).
Kobayashi T; Wada H; Nishioka N; Yamamoto M; Matsumoto T; Tamaru T; Nomura S; Masuya M; Mori Y; Nakatani K; Nishikawa M; Katayama N; Nobori T
Thromb Res; 2008; 121(6):849-54. PubMed ID: 17900666
[TBL] [Abstract][Full Text] [Related]
3. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.
Nguyen TC; Han YY; Kiss JE; Hall MW; Hassett AC; Jaffe R; Orr RA; Janosky J; Carcillo JA
Crit Care Med; 2008 Oct; 36(10):2878-87. PubMed ID: 18828196
[TBL] [Abstract][Full Text] [Related]
4. Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.
Kobayashi S; Yokoyama Y; Matsushita T; Kainuma M; Ebata T; Igami T; Sugawara G; Takahashi Y; Nagino M
Arch Surg; 2012 Oct; 147(10):909-17. PubMed ID: 23117828
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis.
Feys HB; Canciani MT; Peyvandi F; Deckmyn H; Vanhoorelbeke K; Mannucci PM
Br J Haematol; 2007 Aug; 138(4):534-40. PubMed ID: 17608762
[TBL] [Abstract][Full Text] [Related]
6. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
[TBL] [Abstract][Full Text] [Related]
7. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy.
Wickström K; Edelstam G; Löwbeer CH; Hansson LO; Siegbahn A
Scand J Clin Lab Invest; 2004; 64(1):31-40. PubMed ID: 15029874
[TBL] [Abstract][Full Text] [Related]
8. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
9. Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
Sakkinen PA; Cushman M; Psaty BM; Kuller LH; Bajaj SP; Sabharwal AK; Boineau R; Macy E; Tracy RP
Thromb Haemost; 1998 Jul; 80(1):134-9. PubMed ID: 9684799
[TBL] [Abstract][Full Text] [Related]
10. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS-13 antigen and activity levels in thrombocytopenic disorders including thrombotic thrombocytopenic purpura in Kuwait.
Al-Awadhi AM; Jadaon MM; Al-Jafar HA; Al-Wazzan HJ
Acta Haematol; 2011; 125(3):160-6. PubMed ID: 21196718
[TBL] [Abstract][Full Text] [Related]
12. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection.
Sosothikul D; Seksarn P; Pongsewalak S; Thisyakorn U; Lusher J
Thromb Haemost; 2007 Apr; 97(4):627-34. PubMed ID: 17393026
[TBL] [Abstract][Full Text] [Related]
13. Pediatric reference values for molecular markers in hemostasis.
Sosothikul D; Seksarn P; Lusher JM
J Pediatr Hematol Oncol; 2007 Jan; 29(1):19-22. PubMed ID: 17230062
[TBL] [Abstract][Full Text] [Related]
14. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
[TBL] [Abstract][Full Text] [Related]
15. Linear relationship between ADAMTS13 activity and platelet dynamics even before severe thrombocytopenia.
Song J; Lee KA; Park TS; Park R; Choi JR
Ann Clin Lab Sci; 2008; 38(4):368-75. PubMed ID: 18988930
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
17. ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions.
Scully M; Liesner R; Burgess C; Lawrie A; Machin S
Br J Haematol; 2008 Apr; 141(2):262-5. PubMed ID: 18307568
[No Abstract] [Full Text] [Related]
18. Methodologies and clinical utility of ADAMTS-13 activity testing.
Just S
Semin Thromb Hemost; 2010 Feb; 36(1):82-90. PubMed ID: 20391299
[TBL] [Abstract][Full Text] [Related]
19. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
De Filippis V; Lancellotti S; Maset F; Spolaore B; Pozzi N; Gambaro G; Oggianu L; Calò LA; De Cristofaro R
Biochem J; 2012 Mar; 442(2):423-32. PubMed ID: 22091998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
